REFERENCES
- Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contra- ceptives. Lancet 1973;2:926–9
- Caballes RL, Caballes RA. Multiple hepatocellular adenomas in a patient with a history of oral contracep- tion. Int J Gynecol Obstet 1999;64:177–80
- Mathieu D, Kobeiter H, Cherqui D, et al. Oral contra- ceptive intake in women with focal nodular hyperplasia of the liver. Lancet 1998;21:1679–80
- Gugenheim J, Mazza D, Baldini E, et al. Surgical treat- ment of benign hepatic tumors. A safe and efficient choice. Minerva Chir 1995;50:161–5
- Herman P, Machado MA, Volpe P, et al. Transforma- tion of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives. Rev Hosp Clin Fac Med Sao Paulo 1994;49:30–3
- Rabe T, Feldman K, Grundwald K, et al. Liver tumors in women using oral hormonal contraceptives. Zentralbl Gynakol 1995;117:153–6
- Hamrik-Turner JE, Shipkey FH, Cranston PE. Fibro- lamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr 1994;18:301–4
- Matsushita M, Hajiro K, Suzaki T, et al. Focal nodular hyperplasia of the liver without central scar. Dig Dis Sci 1995;40:2407–10
- Saxena R, Humphreys S, Williams R, et al. Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma. Histopathology 1994;25:275–8
- Bassel K, Lee M, Seymour NE. Focal nodular hyper- plasia of the liver. South Med J 1994;87:918–20